Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients

doi:10.3748/wjg.v21.i34.9957

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7143)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

352

WORD

213

HTML

2889

Figures (1-4)

176

Tables (1-3)

158

Sum=3788

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1160

Download

2195

Sum=3355

Sep 14, 2015 (publication date) through Jul 31, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Sep 14, 2015; 21(34): 9957-9965
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.9957

Table 1 Clinical characteristics of patients and healthy controls

Characteristic	HC (n = 83 )	IT (n = 47 )	EPH (n = 93 )	ENH (n = 20 )	IC (n = 55 )
Age (yr)	30.0 (22.0-49.6)	26.0 (20.0-32.2)^a	29.0 (23.0-40.0)	41.0 (20.2-57.8)	32.0 (23.6-46.0)
Sex (male/female)	49/34	29/18	70/23	15/5	30/25
HBV DNA (log₁₀ copies/mL)	ND	7.78 (6.77-8.62)^c	7.07 (5.67-8.05)^c	4.99 (3.76-7.52)	UD
ALT (ULN)	0.42 (0.26-0.77)	0.59 (0.43-0.90)	3.80 (1.94-14.14)^b	2.99 (1.99-11.75)^b	0.59 (0.31-0.89)
Tbil (μmol/L)	13.90 (9.10-21.62)	12.80 (8.60-30.20)	19.20 (12.80-42.90)	16.55 (10.73-28.08)	15.40 (9.38-25.66)

Data shown are the median (10%-90% percentile);

^aP < 0.05 vs all groups;

^bP < 0.05 vs IT and IC;

^cP < 0.01 vs ENH. ALT: Alanine aminotransferase; EPH: HBeAg-positive hepatitis; ENH: HBeAg-negative hepatitis; HBV: Hepatitis B virus; HC: Healthy control; IC: Inactive carrier; IT: Immune tolerance; ND: Not determined; Tbil: Total bilirubin; UD: Undetectable; ULN: Upper limit of normal.

Citation: Huang R, Yang CC, Liu Y, Xia J, Su R, Xiong YL, Wang GY, Sun ZH, Yan XM, Lu S, Wu C. Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients. World J Gastroenterol 2015; 21(34): 9957-9965
URL: https://www.wjgnet.com/1007-9327/full/v21/i34/9957.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i34.9957